7dc2
Á¢Çï¸Õ¹ý£¬µ«¶¥×ÅËÄÊ®¶ÈµÄ¸ßΣ¬¡°ÇïÌìµÄµÚÒ»±Ä̲衱ÕվɵõãÕý³£±ù¡£ Ðí¶àÈËÎÑÔÚ¿Õµ÷·¿ÀïìÅÄ̲衢Ѽ²±ºÍÆ¡¾Æ£¬ÓÐÒ»¸ö¼²²¡È´Ò²ÇÄÈ»ÕÒÉÏÁËÃÅ£¬²»ÊÇ ¸ßѪÌÇ £¬²»ÊǾƾ«¸Î£¬¶øÊÇÁîÐí¶àÄêÇáÈ˶¼Ä¬Ä¬ÖÐǹµÄ¡°¸ßÄòËᡱ¡£ ¾Ý¹ú¼ÒÎÀ½¡Î¯£¬Öйú¸ßÄòËáÈËȺ±ÈÀýÖðÄêÉÏÕÇ£¬²¢ÇÒ·ºÆðÄêÇữÇ÷ÊÆ [1]¡£´ó×ÚÄêÇáÈË£¬ÓÈÆäÊÇÄÐÉúÒѾÌå¼ì³ö¸ßÄòËᣬ¸ßÄòËáÉõÖÁÆÕ±éµ½¿ÉÒԺ͸ßѪ֬¡¢ ¸ßѪѹ ¡¢¸ßѪÌDz¢³Æ¡°Ëĸߡ±¡£ ¹ã¶«È˸üÊÇÔÚ¸ßÄòËáµÄÀ×ÇøÉϲþⱱĵϣ¬ìÒÌÀ¡¢ºÈ¾Æ¡¢³ÔÉúëç¡¢ìÅÌÇË®£¬Ã¿Ñù»áµ¼Ö¸ßÄòËáµÄÐÐΪ¶¼ìî³ýÏ£¬ÄѹÖÓÐË×»°³Æ¡°¹¤¾ßÄϱ±ÖУ¬Í´·ç´ó¹ã¶«¡±¡£ ÿÈý¸ö¹ã¶«ÈË£¬¾ÍÓÐÒ»¸ö¸ßÄòËá
¸ßÄòËᣬ²»ÊÇ˵ÄòÊÇËáµÄ¡£ÔÚҽѧÉÏ£¬ËùνµÄ¡°¸ßÄòËᡱ¾ÍÊǸßÄòËáѪ֢£¨hyperuricemia£¬¼ò³ÆHUA£©£¬ÊÇÈËÌåàÑßÊ´úлÒì³£ÒýÆðµÄ´úлÐÔ¼²²¡ [1]¡£ Ò»Ñùƽ³£ÇéÐÎÏ£¬ÈËÌ屬·¢ºÍÉøÍ¸µÄÄòËáÊÇÆ½ºâµÄ¡£µ«µ±àÑßÊ´úл·ºÆðÕϰ£¬ÄòËáˮƽÉý¸ß£¬¾Í¿ÉÄܵ¼Ö¸ßÄòËáѪ֢¡£ÈËÃdz£ËµµÄ¡°Í´·ç¡±ÊÇÔÚ´Ë»ù´¡ÉϽøÒ»²½Éú³¤£¬ÄòËáÑνᾧ³Á»ýÔÚÊàŦµÈ´¦£¬Òý·¢Ñ×Ö¢ºÍ×éÖ¯ËðÉË [1]¡£ Õý³£Òûʳ״̬Ï£¬·ÇͬÈÕÁ½´Î¼ì²â¿Õ¸¹ÑªÄòËáˮƽ´óÓÚ420 ¦Ìmol/L£¬¼´¿ÉÕï¶ÏΪ¸ßÄòËáѪ֢ [1]¡£ ÖйúÈ˵øßÄòËáÓжàÆÕ±éÄØ£¿ Ò»ÏîÉæ¼°177ƪÑо¿¡¢³¬200Íò¸öÑù±¾µÄÜöÝÍÑо¿²âË㣬Öйú15Ëê¼°ÒÔÉϵÄÈËȺԼÓÐ16.4% »¼ÓиßÄòËáѪ֢ [2]¡£ ÆäÖУ¬ÄÐÐÔ»¼²¡±ÈÀýÊÇ20.4%£¬ÊÇÅ®ÐÔ£¨9.8%£©µÄÁ½±¶»¹¸ß¡£Ò²¾ÍÊÇ˵£¬ÓÐÁè¼ÝÎå·ÖÖ®Ò»µÄ20µ½30ËêµÄÄÐÉú£¬ÄêËêÇáÇáÒѾ¸ßÄòËáÁË [2]¡£ ´ÓÌìϵĸßÄòËáѪ֢»¼²¡ÂÊÀ´¿´£¬ÕûÌåÊǶ¼»á¸ßÓÚÅ©´å£¬Ñغ£¸ßÓÚÄÚ½ [1]¡£º¬¹ã¶«¡¢¹ãÎ÷¡¢º£ÄÏÔÚÄڵĻªÄϵØÇø×î¸ß£¬Îª25.5%£¬Ï൱ÓÚÿËĸö»ªÄÏÈ˾ÍÓÐÒ»¸ö¸ßÄòËá [2]¡£ Æä´ÎÊÇÎ÷ÄϵØÇø£¬Îª21.2%¡£×îµÍµÄÊÇÎ÷±±µØÇø£¬»¼²¡ÂÊÖ»ÓÐ12.6% [2]¡£ Ïêϸµ½¸÷¸öÊ¡·Ý£¬ÁíÒ»ÏîÜöÝÍÆÊÎö·¢Ã÷£¬ºþ±±¡¢É½¶«ºÍÉÂÎ÷ÕâÈýÊ¡µÄ¸ßÄòËáѪ֢×ÜÌ廼²¡ÂÊÊÇ×îµÍµÄ£¬²»µ½10%¡£¶ø¸£½¨¡¢¹ã¶«¡¢¹ãÎ÷¡¢½Î÷¡¢¼ªÁÖ¡¢ÁÉÄþ¡¢ÉϺ£Î»¾ÓǰÏߣ¬Áè¼Ý20% [3]¡£ ÓÈÆäÊǹ㶫¡¢¸£½¨¡¢°²»Õ¡¢¹ãÎ÷¡¢¼ªÁÖµÄÄÐÐÔ£¬Áè¼Ý30% ¶¼ÓиßÄòËáѪ֢ [3]¡£ ÕâÆäÖУ¬±»Öظ´Ìá¼°µÄ¹ã¶«ÈËÄòËá¸ßµ½ÓжàÀëÆ×ÄØ£¿ 2021ÄêµÄÒ»ÏîÑо¿³é²éÁËÖéÈý½ÇµØÇø6491Ãû20Ëêµ½99ËêµÄ¿µ½¡Ìå¼ìÕߣ¬·¢Ã÷34.05% ¶¼ÓиßÄòËᣬÄÐÉú¸ü¿äÕÅ£¬¸ßÄòËá±ÈÀýΪ41.53% [4]¡£ ¹ã¶«ÉõÖÁÁ¬ÖÐѧÉú¶¼¸ßÄòËá¡£¹ãÖÝÊÐÖÐСѧÎÀÉú¿µ½¡Ôö½øÖÐÐijé²é·¢Ã÷£¬¹ãÖݳÇÇø¸ßÖÐÉú¸ßÄòËáˮƽ¼ì³öÂʾ¹¸ß´ï50.37%£¬ÅÂÊǸ߿¼Ñ¹Á¦´ó£¬³ÔÁËÌ«¶à¼Ò³¤Í¶Î¹µÄÀÏ»ðö¦ÌÀ [5]¡£ ³ýÁ˹㶫£¬¸£½¨È˵ÄÄòËáÒ²²»ÂäÏ·硣¾ÝÏÃÃÅ´óѧ¹«¹²ÎÀÉúѧԺµÄÑо¿£¬ÏÃÃųÉÄêסÃñµÄ¸ßÄòËáѪ֢»¼²¡ÂÊΪ27.2%£¬Ò²Ô¶¸ßÓÚÌìÏÂÆ½¾ùˮƽ [6]¡£ Ò²ÄѹÖÓÐÈË˵£¬¹ã¶«È˸ßÄòËᣬû׼ÊÇÓÉÓÚ¸£½¨È˳ԶàÁË¡£ ¾Æ¾«ºÍ¹ûÌÇ£¬¸ßÄòËáµÄ¸ü´óÔªÐ×
¸ßÄòËá»á±äµÃÔÆÔÆÆÕ±é£¬Ôµ¹ÊÔÓÉÐí¶àÈËÏë²»µ½£¬ÆäÖÐÖ®Ò»¾ÓÈ»ÊÇÀ˹ά¼Ó˹9888ÉúÑÄˮƽԽÀ´Ô½ºÃÁË¡£ ÔڹŴú£¬¸ßÄòËáÒý·¢µÄÍ´·çÊdzöÁËÃûµÄ¡°µÛÍõ²¡¡±¡£·¨¹ú¹úÍõ·Ò×ËÄÊÀµÄ¸¸ÏµÖ§ÊôºÍÓ¢¹ú¹úÍõÇÇÖÎÈýÊÀµÄº¢×Ó¶¼ÊÇÍ´·çÊܺ¦Õß [7]¡£ Å¹ú¼ÒÎÞÂÛÊǸßÄòËỼ²¡ÂÊ£¬ÕÕ¾ÉÍ´·ç»¼²¡ÂÊ£¬¶¼ÆÕ±é¸ßÓÚÉú³¤Öйú¼Ò¡£ÃÀ¹ú¡¢ÈÕ±¾µÄ¸ßÄòËá±ÈÀý¶¼Áè¼Ý20%£¬¶øÌ©¹ú¡¢ÍÁ¶úÆäµÈÉú³¤Öйú¼Ò£¬ÕâÒ»Êý×Ö²»µ½15% [8]¡£ Ëæ×ÅÖйú¾¼ÃÉú³¤£¬ÕâЩÄêÀ´£¬¸ßÄòËáѪ֢»¼²¡ÂÊÒ²ÔÚÔ½À´Ô½¸ß [2]¡£ Ò»ÏîÃæÏòÖйú31Ê¡·Ý£¨²»º¬Öйú¸Û°Ą̈µØÇø£©¡¢½ü°ËÍòÈ˵ÄÑо¿Í¬Ñù·¢Ã÷£¬ÄêÊÕÈëÒ»Íòµ½Ê®ÍòÒÔÉϵÄÈËȺÖУ¬¸ßÄòËáѪ֢»òÍ´·ç»¼²¡ÂÊÕûÌå¶¼Ëæ×ÅÄêÊÕÈëÔöÌí¶øÔöÌí [9]¡£ ÄêÊÕÈëÊ®ÍòÔªÒÔÉϵÄÈËȺ£¬¸ßÄòËáѪ֢»¼²¡ÂÊΪ21.4%£¬Òª½üÄêÊÕÈëÎåÍòµ½Ê®ÍòÔªµÄÈ˺á¿ç3.4¸ö°Ù·Öµã [9]¡£ Ϊʲô»áÔÆÔÆ£¿ÕâÒª´ÓÄòËáµÄȪԴÌá¼°¡£ ÄòËáÊÇÓÉàÑßÊ´úл¶ø³ÉµÄ£¬ÌåÄÚµÄÄòËáÓÐ80% À´×ÔÄÚÔ´ÐÔµÄàÑßÊ´úл£¬ÉÐÓÐ20% ÊÇÍâÔ´µÄʳÎﱬ·¢ [10]¡£ ÒÔÊÇ¿ÉÒÔ˵£¬ÈËÌåÄòËáˮƽÆéá«£¬Ö±½ÓÊܵ½ÒûʳµÄÓ°Ïì¡£ Ò»·½Ã棬Äã³Ô½øÀ´µÄàÑßʶàÁË£¬´úл¶ø³ÉµÄÄòËáÒ²¾Í¶àÁË¡£ºÃ±ÈÈâÀà¡¢º£ÏÊ¡¢ÄÚÔà¾ÍÊǵ䷶µÄ¸ßàÑßÊʳÎï¡£¹ã¶«È˰®²»ÊͿڵĶì¸üÊÇàÑßÊ¡°¶¥Á÷¡±£¬Ã¿100¿Ë¶ì¸Î¾ÍÓÐ377ºÁ¿ËàÑßÊ [1]¡£ 2015ÄêÒ»ÏîÃæÏò¸£½¨2666Ãû³ÉÄêסÃñµÄÊÓ²ìÒ²·¢Ã÷£¬ÈôÊǽ«ÈËÃǵÄÉÅʳģʽ·ÖΪ¹Å°åÐÍ¡¢¶¯ÎïÐÔʳÎïÐÍ¡¢Ñغ£ÐÍ¡¢ÓÅÖÊÂѰ×ÐÍ£¬ÆäÖж¯ÎïÐÔʳÎïÐͺÍÑØº£ÐÍÈËȺµÄ¸ßÄòËỼ²¡ÂÊÊÇ×î¸ßµÄ£¬ÕâÁ½ÕßÖ÷Òª³ÔµÄ¾ÍÊÇÈâºÍº£ÏÊ [11]¡£ ÁíÒ»·½Ã棬ÓÐЩÉúÑÄϰ¹ß×Ô¼º²»»áÔöÌíÍâÔ´ÐÔàÑßʵÄÉãÈ룬µ«Ó°ÏìÁËÈËÌåµÄ´úл£¬Ò²»áµ¼Ö¸ßÄòËá ¡£ ×îµä·¶µÄ¾ÍÊǺȾơ£¾Æ¾«ËäÈ»²»ÊÇàÑßÊ£¬µ«¾Æ¾«ÔÚÌåÄÚ´úлʱ»áÔöÌíÄÚÔ´ÐÔàÑßʵÄÌìÉú£¬´Ó¶øÉý¸ßÈËÌåµÄÄòËáˮƽ£¬Î£º¦²»±È¸ßàÑßÊʳÎïС [12]¡£ ±ðµÄ£¬¹ûÌǵÄΣº¦Ò²ÈÝÒ×±»ºöÊÓ¡£ËäÈ»Ëü¿´×ÅÈËÐóÎÞº¦£¬µ«¹ýÁ¿ÉãÈëºóÒ²¿ÉÄÜ»áÓÕ·¢ÄòËáˮƽµÄÉý¸ß [2]¡£Éñ¾¿ÆÑ§¼Ò´÷ά¡¤çê¶ûÂíÌØ¸üÊÇÔÚ¡¶²þâ±µÄÄòËá¡·Ò»ÊéÖÐÖ±Ö¸£¬¹ýÁ¿µÄ¹ûÌÇÉãÈëÒѾ³ÉÁËÏÖ´úÈ˸ßÄòËáµÄÔªÐ× [13]¡£ ËäȻˮ¹ûÀïÒ²ÓйûÌÇ£¬µ«ÏÖ´úÈ˹ûÌÇÉãÈ볬±êÍùÍù²»ÊÇË®¹ûµÄ¹ø£¬¶øÊÇÓÉÓÚÆÕ±é±£´æÓÚ¾«¼Ó¹¤µÄÌðÆ·¡¢ÌðÒûÁÏÖеĹûÌÇ£¬ÀýÈçËæ´¦¿É¼ûµÄ¹ûÆÏÌǽ¬£¬Ö÷ÒªÒòËØ¼´ÊǹûÌÇ [13]¡£ ³ýÁËÒûʳ£¬µ¼Ö¸ßÄòËáµÄÁíÒ»´ó¡°É±ÊÖ¡±ÊÇ·ÊÅÖ¡£ ·ÊÅÖ»á¸Ä±äÉíÌå´úл£¬ÄÜÔöÌíÄòËáÔÚ¸ÎÔàÖеĺϳɡ¢ïÔÌÔÚÉöÔàÖеÄÉøÍ¸ [13]¡£±±¾©ÐºÍÒ½ÔºµÄÑо¿Åú×¢£¬ÔÚÌåÖ¬ÂÊСÓÚ34.3% µÄÄÐÉúÖУ¬ÌåÖ¬ÂÊÿÉÏÉý1%£¬ÑªÇåÄòËá¾ÍÔöÌí1.97 ¦Ìmol/L [14]¡£ ½²µ½ÕâÀÃÕµ×Ò²Öð½¥Ã÷Îú¡£µ¼Ö¸ßÄòËáµÄÖ÷ÒªÒòËØÇ¡Ç¡¾ÍÊǾ¼ÃÅµØÇø×¡ÃñµÄÌØµã£º·ÊÅÖÂʸߣ¬ÉúÑÄÌõ¼þºÃ£¬Ò»Ñùƽ³£ÉúÑľÍÊÇ´óÓã´óÈâÅäÉÏŨÌÀÇí½¬¡£ ¸ßÄòËáµÄΣº¦£¬±»ÑÏÖØµÍ¹À
ÏÖÔÚ£¬Ðí¶àÄêÇáÈ˱»²é³ö¸ßÄòËᣬµ«ÈÔ²»·ÅÔÚÐÄÉÏ¡£±ð¿´ÄòËáÖ»ÊǸö²»ÆðÑÛµÄÊý×Ö£¬Ò»µ©Ò»Á¬ºá¿çÕý³£Ë®Æ½£¬Ð§¹ûÕÕ¾ÉÂù¶àµÄ¡£ Ö÷ÒªµÄ¾ÍÊǸ÷ÈËÊìÖªµÄÍ´·ç¡£ Í´·çÈ«³ÆÊǼ±ÐÔÍ´·çÐÔÊàŦÑ×£¬Ö®ÒÔÊǽÐÍ´·ç£¬¾ÍÓÉÓÚÕâÖÖ²¡ÕæµÄºÜ´õ¶¾£¬¾ÍÏñ·çÒ»Ñùƽ³£ÄÑÒÔ×½Ãþ¡£±¬·¢µÄµä·¶Àú³ÌÊÇÉÏ´²Ë¯¾õʱ»¹ºÃºÃµÄ£¬ºóÈý¸ü¾ÍÓÉÓÚ½ÅÍ´Í´ÐÑ [1]¡£ ²¢ÇÒÍ´·çÍ´ÆðÀ´ºÜÒªÃü¡£Ó¢¹úÖøÃûÂþ»¼Òղķ˹¡¤¼ª¶ûÈðÔÚ1799Äê½ÒÏþµÄ¡¶Í´·ç¡·Âþ»ÖУ¬°ÑÍ´·çÃè»æ³ÉÒ»¸öÕýÔÚ¿ÐÊÉÈ˽ŵÄÐþÉ«Ñý¹Ö£¬ËµËºÐÄÁÑ·ÎÊÇÒ»µãÒ²²»¿äÕÅ [15]¡£ ³ýÁËÌÛÍ´£¬²»×ö½µÄòËáÖÎÁƵϰ£¬Í´·ç»¼ÕßµÄÊàŦ´¦»¹»áÓÉÓÚÄòËáÑξ§Ìå³Á»ý³¤³öÍ´·çʯ£¬ÑÏÖØµÄ»¹»áÊàŦ»ûÐΣ¬ÉõÖÁ¹ÇÕÛ [16]¡£ ²»ÊÇËùÓеĸßÄòËáÈËȺ¶¼»áµÃÍ´·ç£¬µ«¶þÕßÊÇÇ×½üÏà¹ØµÄ¡£Æ¾Ö¤ÎÀ½¡Î¯Í³¼Æ£¬Ã¿100λ¸ßÄòËáѪ֢»¼ÕßÖУ¬Ô¼ÓÐ6µ½16ÈË»áÉú³¤ÎªÍ´·ç [1]¡£ ²»µ«Í´·ç£¬Ô½À´Ô½¶àÑо¿Åú×¢£¬¸ßÄòËáºÍ¸ßѪѹ¡¢ÐÄÔಡ¡¢ÂýÐÔÉöÔಡ¡¢ÌÇÄò²¡µÈÖî¶àÂýÐÔ²¡Ö®¼ä±£´æ¹ØÁª¡£ ÀýÈç¸ßÄòËáˮƽ»áÒý·¢Ò»ÏµÁб»³ÆÎª¡°Ñõ»¯Ó¦¼¤¡±µÄÉú»¯·´Ó¦£¬´Ó¶øµ¼ÖÂѪ¹ÜËõ¶Ì£¬Ê¹µÃÐÄÔàÒªÔ½ÌáÒé¾¢µØÔö½øÑªÒºÑ»·£¬ÑªÑ¹Ò²Òò´Ë¶øÉý¸ß [13]¡£ ¸ßÄòËỹ»á·´¹ýÀ´¼Ó¾ç·ÊÅֵı¬·¢¡£½ÒÏþÔÚ¡¶ÐÄÀíѧÓëÐÐΪѧ¡·ÉϵÄÒ»ÏîÑо¿Åú×¢£¬ÄòËáµÄ»ýÀÛ»áÔöÇ¿¹ûÌǵÄ×÷Óã¬ÒÖÖÆÊÝËØ£¨Ò»ÖÖÈÃÈË×èÖ¹½øÊ³µÄ¼¤ËØ£©ÉøÍ¸£¬´Ó¶ø»ýÀÛ¸ü¶àÖ¬·¾ [17]¡£ 2020Ä꣬ÈÕ±¾É½ÐδóѧÖ÷µ¼µÄÒ»ÏîÑо¿ÖУ¬Ñо¿Ö°Ô±ÓÃÆßÄêʱ¼ä¸ú×ÙÊÓ²ì50¶àÍòÈË£¬·¢Ã÷¸ßÄòËáˮƽ»áÏÔÖøÔöÌíéæÃüΣº¦ [18]¡£ ËäÈ»£¬Òª×èÖ¹¸ßÄòËᣬҪÁìÕÕ¾ÉÐí¶àµÄ¡£ Ò»¸ö¾ÍÊÇÒª×¢ÖØÒûʳ¡£¶à³ÔÊ߲ˣ¬ïÔ̾ƾ«ºÍ¹ûÌÇÉãÈë¡£¿ÉÒÔÊÊÁ¿ÒûÓõÍÖ¬¡¢ÍÑ֬ţÄ̼°ÈéÖÆÆ·£¬Ö»¹Ü²»ºÈ¿ÉÀÖ¡¢³ÈÖ¡¢Æ»¹ûֵȺ¬¹ûÌÇÒûÁÏ»òº¬ÌÇÈíÒûÁÏ [19]¡£ ÒѾ±»¼ì²â³öÄòËá¸ßµÄÈË»¹ÒªÉÙ³ÔЩº£ÏʺÍÈ⣬¿´×Å×̲¹µÄÀÏĸ¼¦ÌÀ£¬Ã»×¼¾ÍÊÇÒ»Íë¡°àÑßÊÕ¨µ¯¡±¡£ ±ðµÄ£¬¶àÔ˶¯¡¢×ãÁ¿ºÈˮҲ¶Ô½µÄòËáÓÐ×ÊÖú£¬Ç°Õß¿ÉÒÔ×ÊÖú¿ØÖÆÌåÖØ£¬ºóÕß¿ÉÒÔ¼ÓËÙÄòËáÉøÍ¸ [1]¡£ ×ܶøÑÔÖ®£¬Ö»Òª¹Üס×죬Âõ¿ªÍÈ£¬¶ÌÔÝÉý¸ßµÄÄòËáÕվɺܿÉÄܽµÏÂÀ´µÄ¡£Ö»Íïϧ£¬ºÃ³ÔµÄ¹¤¾ßƫƫ´ó´ó¶¼¶¼²»¿µ½¡£¬Ò²Ðí¼á³Ö¿µ½¡µÄ±Ø±¸ÏÈÌ죬³ýÁËÄܶ¯ÄÜ˯ÒÔÍ⣬»¹ÒªÃ»ÓÐζ¾õ¡£
±¾ÎÄ¿ÆÑ§ÐÔÒÑÓÉÅ®Íõ´óѧ²¡Àí¼°·Ö×Óҽѧ˶ʿ ÎéÀöÇà ÉóºË
²Î¿¼×ÊÁÏ [1] ¹ú¼ÒÎÀÉú¿µ½¡Î¯. (2024). ³ÉÈ˸ßÄòËáѪ֢ÓëÍ´·çÊ³ÑøÖ¸ÄÏ. [2] Li, Y., Shen, Z., Zhu, B., Zhang, H., Zhang, X., & Ding, X. (2021). Demographic, regional and temporal trends of hyperuricemia epidemics in mainland of China from 2000 to 2019: a systematic review and meta-analysis. Global health action, 14(1), 1874652. [3] Huang, J., Ma, Z. F., Zhang, Y., Wan, Z., Li, Y., Zhou, H., ... & Lee, Y. Y. (2020). Geographical distribution of hyperuricemia in mainland of China: a comprehensive systematic review and meta-analysis. Global Health Research and Policy, 5, 1-18. [4] Liu, W., Liu, W., Wang, S., Tong, H., Yuan, J., Zou, Z., ... & Xie, Z. (2021). Prevalence and risk factors associated with hyperuricemia in the Pearl River Delta, Guangdong Province, China. Risk Management and Healthcare Policy, 655-663. [5] µËðØ, & ¶ÅѩӨ. (2019). ¹ãÖݳÇÇø¸ßÖÐÉúѪÄòËáˮƽ¼°Ó°ÏìÒòËØÆÊÎö. ÖйúѧУÎÀÉú, 40(9), 1420-1422. [6] »Æ¼ÑÀÖ, ÍõÐÂÔÂ, & ÀîºìÎÀ. (2019). ÏÃÃÅÊÐסÃñ¸ßÄòËáѪ֢ÓëÉÅʳàÑßÊÉãÈëµÄÏà¹ØÐÔÑо¿. Acta Nutrimenta Sinica, 41(1). [7] Bhattacharjee, S. (2009). A brief history of gout. International Journal of Rheumatic Diseases, 12(1), 61-63. [8] She, D., Wang, Y., Liu, J., Luo, N., Feng, S., Li, Y., ... & Zhang, Z. (2022). Changes in the prevalence of hyperuricemia in clients of health examination in Eastern China, 2009 to 2019. BMC Endocrine Disorders, 22(1), 202. [9] Song, J., Jin, C., Shan, Z., Teng, W., & Li, J. (2022). Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland of China. Journal of translational internal medicine, 10(2), 134-145. [10] Zhang, M., Wang, Y., Wang, K., Yin, R., Pan, X., & Ma, A. (2021). Association between uric acid and the prognosis of acute ischemic stroke: A systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 31(11), 3016-3023. [11] ÁÖÉÙ¿, ÀµÉÆéÅ, »Æá¿, ÑôÀö¾ý, & Îâ»Ûµ¤. (2018). ¸£½¨Ê¡×¡ÃñÉÅʳģʽ¼°¸ßÄòËáѪ֢ӰÏìÒòËØ·ÖÀàÊ÷ÆÊÎö. Öйú¹«¹²ÎÀÉú, 34(6), 798-802. [12] Li, R., Yu, K., & Li, C. (2018). Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review. Asia Pacific journal of clinical nutrition, 27(6), 1344-1356. [13] ´÷ά¡¤çê¶ûÂíÌØ. (2023). ²þâ±µÄÄòË᣺²»Ö¹ÊÇÍ´·ç. ±±¾©¿ÆÑ§ÊÖÒÕ³öÊéÉç. [14] Sun, J., Yue, C., Liu, Z., Li, J., & Kang, W. (2022). The association between total percent fat and serum uric acid in adults. Frontiers in Nutrition, 9, 851280. [15] James Gillray. (1799). The gout. National Portrait Gallery. Retrieved on August 8th, 2024, from https://www.npg.org.uk/collections/search/portrait/mw62371/The-gout. [16] Áõ¾², ³Â«hÇÅ, ³ÂÇïÖ¾, ì¶Ò»·², Áõ°ÁÄÐ, Ö£ÎäÑà, ÂÀÍòƼ, ¹ùÒÔ´¨, & ÑîÑÞ·¼. (2022). Í´·ç»¼ÕßÍ´·çʯÐγÉÏÖ×´¼°Ïà¹ØÒòËØÆÊÎö. ÏÖ´úÔ¤·Àҽѧ, 2022, 49(17):3252-3259. [17] Figlewicz, D. P., Ioannou, G., Jay, J. B., Kittleson, S., Savard, C., & Roth, C. L. (2009). Effect of moderate intake of sweeteners on metabolic health in the rat. Physiology & Behavior, 98(5), 618-624. [18] Konta, T., Ichikawa, K., Kawasaki, R., Fujimoto, S., Iseki, K., Moriyama, T., ... & Watanabe, T. (2020). Association between serum uric acid levels and mortality: a nationwide community-based cohort study. Scientific reports, 10(1), 6066. [19] ¹ú¼ÒÎÀÉú¿µ½¡Î¯. (2023). ³ÉÈ˸ßÄòËáѪ֢ÓëÍ´·çÊ³ÑøÖ¸ÄÏÌåÀý˵Ã÷.